Camena Bioscience

Cambridge, United Kingdom

Camena Bioscience is a synthetic biology company that develops tools to engineer new synthetic biology applications.

$10.0M raised

Jul 2023

Series A

Biotechnology Health Care

Top Investors

Mercia Asset Management

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Camena Bioscience

How much funding has Camena Bioscience raised?

Camena Bioscience has raised $10.0M in total funding. The most recent round was Series A. The last funding was announced in July 2023.

Who are Camena Bioscience's investors?

Camena Bioscience's investors include Mercia Asset Management.

Where is Camena Bioscience headquartered?

Camena Bioscience is headquartered in Cambridge, United Kingdom.

What does Camena Bioscience do?

Camena Bioscience is a synthetic biology company that develops tools to engineer new synthetic biology applications.

What stage is Camena Bioscience at?

Camena Bioscience is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 3, 2023.

MLA

"Camena Bioscience — Funding & Investors." VCBacked, July 3, 2023, https://www.vcbacked.co/company/camena-bioscience. Accessed June 5, 2026.

APA

VCBacked. (2023). Camena Bioscience — Funding & Investors. Retrieved June 5, 2026, from https://www.vcbacked.co/company/camena-bioscience

Wikipedia (cite web)

{{cite web |title=Camena Bioscience — Funding & Investors |url=https://www.vcbacked.co/company/camena-bioscience |website=VCBacked |access-date=June 5, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 3, 2023.

Similar Companies in Biotechnology